For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
12
views
0
references
 Top references
cited by
59
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      2,363
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Composite end points in randomized trials: there is no free lunch.

      Author(s):
      Publication date:
      Journal: JAMA
      Keywords: Decision Making, Diabetes Mellitus, mortality, prevention & control, Endpoint Determination, Humans, Hypoglycemic Agents, therapeutic use, Randomized Controlled Trials as Topic, Thiazolidinediones, Treatment Outcome

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 20085955
          DOI:: 10.1001/jama.2009.2017

          ScienceOpen disciplines: Chemistry
          Keywords: Decision Making,Diabetes Mellitus,mortality,prevention & control,Endpoint Determination,Humans,Hypoglycemic Agents,therapeutic use,Randomized Controlled Trials as Topic,Thiazolidinediones,Treatment Outcome
          Data availability:
          ScienceOpen disciplines: Chemistry
          Keywords: Decision Making, Diabetes Mellitus, mortality, prevention & control, Endpoint Determination, Humans, Hypoglycemic Agents, therapeutic use, Randomized Controlled Trials as Topic, Thiazolidinediones, Treatment Outcome

          Comments

          Comment on this article

          scite_

          Similar content2,363

          See all similar

          Cited by24

          See all cited by